Ybarra Luiz Fernando, Cantarelli Marcelo J C, Lemke Viviana M G, Quadros Alexandre Schaan de
McGill University Health Centre, Montreal - Canadá.
Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista, São Paulo, SP - Brazil.
Arq Bras Cardiol. 2018 May;110(5):476-483. doi: 10.5935/abc.20180077.
Percutaneous coronary intervention in chronic total occlusion is a rapidly evolving area, being considered the last frontier of interventional cardiology. In recent years, the development of new techniques and equipment, as well as the training of specialized personnel, increased their success rates, making it the most predictable procedure available. Although the number of randomized and controlled studies is still limited, results from large multicentered registries allow us to safely offer this intervention to patients, as another treatment option along with the optimized drug treatment and myocardial revascularization surgery. This review summarizes the last and most relevant publications in the subject in order to provide an overall view of the field's current status.
慢性完全闭塞病变的经皮冠状动脉介入治疗是一个快速发展的领域，被视为介入心脏病学的最后前沿阵地。近年来，新技术和设备的发展以及专业人员的培训提高了其成功率，使其成为现有最可预测的手术。尽管随机对照研究的数量仍然有限，但大型多中心注册研究的结果使我们能够安全地为患者提供这种干预措施，作为优化药物治疗和心肌血运重建手术之外的另一种治疗选择。本综述总结了该主题的最新及最相关的出版物，以便对该领域的当前状况提供一个全面的视角。
